Jasperware and all, I think that we're falling into the same trap predicting too tight a timeframe for the BN in January. Let's all just accept a BN is probable early next year sometime, most probably January but could be February too. When it comes, it comes. Looks at the disappointment the timing of the Dec update has caused...do we really want to do this again????
Jan-mar, I would be happy for a takeover bid because it would value the company more appropriately, and it doesn't mean that we or the board have to accept the bid. Personally, I think that RT is setting up Dexo to eventually spin-off/JV Wafertab, or to sell it outright. There's really no other reason for not using Tampa. By keeping Dexo (Wafertab) as a completely seperate subsiduary, then it does away with the pain of having the split it apart from Soluleave when/if a pharma decides to buy it. A pharma would not be interesting in vitamins etc so would probably not want to buy that part of the business too.
Bioprogress stock quotes
Bioprogress stock charts
Follow this thread
